Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information Jun 29, 2026 04:29PM
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026 Jun 23, 2026 07:00AM
Elite Pharmaceuticals completes bioequivalence study for anticonvulsant Jun 15, 2026 07:03AM
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study Jun 15, 2026 07:00AM
Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant Product Jun 1, 2026 07:00AM


Apr 2, 2026 08:01AM Elite Pharmaceuticals launches generic methadone tablets
Apr 2, 2026 08:00AM Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets
Feb 17, 2026 04:19PM Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information
Feb 11, 2026 04:30PM Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026
Nov 14, 2025 04:19PM Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information
Nov 10, 2025 07:00AM Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025
Aug 14, 2025 04:24PM Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2026 ended June 30, 2025 and Provides Conference Call Information
Aug 8, 2025 04:30PM Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2026 Financial Results on August 15, 2025
Jun 30, 2025 04:13PM Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2025 and Provides Conference Call Information
Jun 23, 2025 07:00AM Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2025 Financial Results on July 1, 2025
Jun 16, 2025 07:00AM Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Apr 30, 2025 04:30PM Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
Mar 3, 2025 07:00AM Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
Feb 13, 2025 04:22PM Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information
Feb 10, 2025 04:54PM Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025
Dec 26, 2024 07:01AM Elite Pharmaceuticals, Inc. (ELTP) Announces Commercial Launch of Generic Vyvanse
Dec 26, 2024 07:00AM Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)
Dec 2, 2024 06:00AM Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets
Nov 18, 2024 06:39AM Elite Pharmaceuticals (ELTP) Receives FDA Approval for Generic Vyvanse
Nov 18, 2024 06:00AM Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
Nov 14, 2024 04:38PM Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information
Nov 7, 2024 07:00AM Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024
Oct 10, 2024 04:41PM Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health
Oct 7, 2024 07:30AM Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Codeine Phosphate Tablets
Aug 27, 2024 07:00AM Elite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium
Aug 14, 2024 05:09PM Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information
Aug 9, 2024 04:00PM Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024
Jul 1, 2024 05:06PM Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information
Jun 26, 2024 03:00PM Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024